U.S. Markets close in 2 hrs 42 mins
  • S&P 500

    3,944.84
    -3.88 (-0.10%)
     
  • Dow 30

    32,081.24
    -24.01 (-0.07%)
     
  • Nasdaq

    11,734.32
    -53.08 (-0.45%)
     
  • Russell 2000

    1,721.96
    +1.67 (+0.10%)
     
  • Crude Oil

    69.09
    -0.87 (-1.24%)
     
  • Gold

    1,989.00
    -6.90 (-0.35%)
     
  • Silver

    23.38
    +0.12 (+0.53%)
     
  • EUR/USD

    1.0762
    -0.0075 (-0.6888%)
     
  • 10-Yr Bond

    3.3670
    -0.0390 (-1.15%)
     
  • Vix

    22.85
    +0.24 (+1.06%)
     
  • GBP/USD

    1.2217
    -0.0071 (-0.5803%)
     
  • USD/JPY

    130.7330
    -0.0560 (-0.0428%)
     
  • BTC-USD

    27,838.10
    -486.74 (-1.72%)
     
  • CMC Crypto 200

    606.01
    -12.37 (-2.00%)
     
  • FTSE 100

    7,405.45
    -94.15 (-1.26%)
     
  • Nikkei 225

    27,385.25
    -34.36 (-0.13%)
     

Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?

Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?

Lilly's FDA rejection puts Biogen and its partner Eisai in the driver's seat in the Alzheimer's disease drug market.